Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Xoma Corp 8.625% (XOMAP)

Xoma Corp 8.625% (XOMAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events

Added six assets to its portfolio of potential milestone and royalty assets in 2021

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMAO : 25.56 (-0.64%)
XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events

XOMA’s portfolio of potential milestone and royalty assets now has greater than 70 drug candidates. Company ended the first quarter of 2021 with $67.8 million in cash.  The April 2021 $40 million...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)
XOMA Announces Approval of First Preferred Stock Dividend

EMERYVILLE, Calif., March 22, 2021 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors approved a dividend of $0.71875 per share...

XOMA : 26.62 (-1.88%)
XOMAP : 25.90 (+0.15%)

Barchart Exclusives

1 Penny Stock Wall Street Expects to Soar 100% in 2025
This penny stock is making its way through the artificial intelligence wave. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar